$0.00
(+0.00%
) Quote detailsUSD
+$0.00
(+0.00%
)At Close (As of Nov 28, 2025)
$307.27M
Market Cap
-
P/E Ratio
-1.78
EPS
$5.12
52 Week High
$0.24
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Relmada Therapeutics, Inc. is a clinical-stage biotechnology firm headquartered in New York, dedicated to pioneering novel therapies for central nervous system (CNS) disorders and related conditions. The company is advancing a promising pipeline targeting unmet medical needs in pain management and psychiatric disorders, leveraging innovative research and technology. With a strong emphasis on improving patient outcomes, Relmada is well-positioned to play a pivotal role in the dynamic CNS therapeutics landscape, potentially delivering transformative solutions for both patients and healthcare providers.
LPTX
KTTA
NVDA
HBI
TLRY
INTC
BITF
IPG
BYND
CLSK
ADAP
ASST
PLUG
SNAP
BIYA
AAL
TSLA
CIFR
MARA
WULF
NIO
F
MTSR
VALE
SOFI
GOOGL
BTBT
ADTX
GRAB
DVLT
PFE
CAN
DNN
IBRX
RIOT
WBD
AG
APLD
GOOG
IREN
RIG
BAC
AMD
SMR
TMC
CDE
PLTR
ITUB
AGNC
T
AMC
VHAI
NVO
META
MSTR
NFLX
SAND
MSFT
HBAN
HL
LPTX
KTTA
NVDA
HBI
TLRY
INTC
BITF
IPG
BYND
CLSK
ADAP
ASST
PLUG
SNAP
BIYA
AAL
TSLA
CIFR
MARA
WULF
NIO
F
MTSR
VALE
SOFI
GOOGL
BTBT
ADTX
GRAB
DVLT
PFE
CAN
DNN
IBRX
RIOT
WBD
AG
APLD
GOOG
IREN
RIG
BAC
AMD
SMR
TMC
CDE
PLTR
ITUB
AGNC
T
AMC
VHAI
NVO
META
MSTR
NFLX
SAND
MSFT
HBAN
HL